日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Global cancer statistics for children: Two decades of change and projections to 2050

全球儿童癌症统计数据:二十年来的变化及至2050年的预测

Li, Wangzhong; Huang, Shanzhou; Chen, Qiyue; Wang, Ting; Lu, Guanming; Niu, Xing; Song, Qiong; Xu, Yilin; Mo, Ke; Cui, Chunhui; Zhang, Run; Du, Wei; He, Feiying; Shi, Lei; Lin, Yan; Wei, Qiu; Jiang, Li; Chen, Yongsheng; Song, Baiyang; Zhang, Huijuan; Fu, Zhenli; Liao, Wenjing; Sun, Jiancong; Guan, Wenhui; Zhuang, Weitao; Zhong, Nanshan; Zhou, Chengzhi; Liang, Wenhua; Kang, Min; He, Jianxing

Engineering plasmids with synthetic origins of replication

构建具有合成复制起点的质粒

Liu, Baiyang; Seet, Zhi Ren Darren; Peng, Xiao; Bennett, Matthew R; Lakin, Matthew R; Chappell, James

A domain-adaptive deep contrastive network for magnetic resonance imaging-driven bladder cancer classification

一种用于磁共振成像驱动的膀胱癌分类的域自适应深度对比网络

Huang, Junjun; Hu, Haixia; Sun, Mengdan; Wu, Weiting; Xu, Keyi; Xu, Juan; Sun, Xufeng; Hu, Dongdong; Yao, Dandan; He, Tianran; Wei, Wei; Song, Baiyang; Fang, Li

Controlled Optically Active Hierarchical Nanostructures of Side-Chain Sequence-Regulated Graphene Nanoribbons

侧链序列调控的石墨烯纳米带可控光学活性分级纳米结构

Chen, Baiyang; Song, Kaiyuan; Yu, Li; You, Lujia; Wang, Yiming; Zhang, Zhaoguo; Zhou, Yongfeng; Zhu, Xinyuan; Dong, Ruijiao

TRIM21-mediated degradation of HILPDA overcomes anti-PD-1 immunotherapy resistance in breast cancer by limiting PD-L1 palmitoylation

TRIM21介导的HILPDA降解通过限制PD-L1棕榈酰化克服乳腺癌中的抗PD-1免疫疗法耐药性。

Wang, Xi; Li, Guangyan; Wu, Jiaming; Fu, Baiyang; Zhang, Haoyang; Chen, Yichi; Wang, Jianjiao; Zhang, Jianguo; Chen, Xi

Development and validation of a TOP2A based index clinical model for kidney renal clear cell carcinoma

基于TOP2A的肾透明细胞癌临床模型的开发与验证

Shi, Xiaodong; Song, Baiyang; Wang, Boqian; Chen, Anyi; Hu, Jiasheng; Xie, Guohai; Huang, Jialing; Huang, Caiyun; Cheng, Yue; Yan, Zejun; Du, Wei

Plant natural products targeting NLRP3 inflammasome in Parkinson's disease: Molecular activation and regulation to therapeutics

植物天然产物靶向帕金森病中的NLRP3炎症小体:从分子激活和调控到治疗

Lu, Hao; Zeng, Fengyi; Sun, Jiao; Li, Baiyang; Lei, Zhimei; Zeng, Chenyu; Zhu, Chendan; Sheng, Yanmei; Peng, Quekun; Sun, Yiran; Zhang, Shiyan

Association of peripheral insulin resistance with cognitive impairment in patients with non-disabling ischemic cerebrovascular events and the mediating role of chronic inflammatory biomarkers

外周胰岛素抵抗与非致残性缺血性脑血管事件患者认知障碍的关联以及慢性炎症生物标志物的介导作用

Zhang, Liren; Nie, Qianqian; Zheng, Baiyang; Gu, Zhengsheng; Kan, Yuting; Sun, Xu; Zheng, Wensi; Bi, Xiaoying

Deciphering the eRNA landscape and revealing target aberrant pathways in prostate cancer

解读前列腺癌中的eRNA图谱并揭示靶向异常通路

Yu, Chengling; Wen, Yong; Li, Yanguo; Song, Baiyang; Hu, Yiwei; Meng, Zixing; Yan, Zejun; Du, Wei; Rong, Hao

Exploratory Investigation Into Perioperative Treatment Strategies for Potentially Resectable Stage III-N2 Driver Gene-Negative Non-Small Cell Lung Cancer in the Immunotherapy Era

免疫治疗时代潜在可切除的III-N2期驱动基因阴性非小细胞肺癌围手术期治疗策略的探索性研究

Zhao, Jiarui; Huang, Baiyang; Li, Min; Wang, Xingpeng; Zhu, Jingyu; Wang, Kaiyue; Xu, Jing; Wang, Xiaohan; Bai, Menglin; Cai, Guoxin